Sunesis Pharmaceuticals Competitors and Similar CompaniesClear all

Sunesis Pharmaceuticals's competitors and similar companies include Takeda, PLIVA, Biocon and Shanghai Junshi Biosciences.
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
Takeda
Takeda
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
PLIVA
PLIVA
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
Biocon
Biocon
Biocon is a global biopharmaceutical company.
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date
Founding Date
1987
Founding Date
1781
Founding Date
1921
Founding Date
1978
Founding Date
2012
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Tags
Locations
Locations
South San Francisco, US HQ
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Zagreb, HR HQ
Sarajevo, BA
Skopje, MK
Belgrade, RS
Locations
Bengaluru, IN HQ
Bengaluru, IN
Hyderabad, IN
Visakhapatnam, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
see more
Locations
Shanghai, CN HQ
Employees
Employees
43
Employees
49,281
Employees
1,6451% decrease
Employees
16,315
Employees
2,5321% decrease

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥4.3t (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
₹142b (FY, 2024)
Revenue (est.)
¥1.5b (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
¥698.7b (FY, 2024)
Cost of goods
N/A
Cost of goods
₹50.9b (FY, 2024)
Cost of goods
¥541m (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
¥3.6t (FY, 2024)
Gross profit
N/A
Gross profit
₹102b (FY, 2024)
Gross profit
¥941.9m (FY, 2023)
Net income
Net income
($114.8m) (FY, 2021)
Net income
¥144.2b (FY, 2024)
Net income
N/A
Net income
₹13b (FY, 2024)
Net income
(¥2.5b) (FY, 2023)

Funding

Total funding raised
Total funding raised
$ 171.7m
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Takeda
HQ
Tokyo, JP
Employees
49,281

Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
PLIVA
HQ
Zagreb, HR

PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,315

Biocon is a global biopharmaceutical company.

View company
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,532↓ 1% decrease

Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.

View company